Effects of taurine deficiency and chronic methanol administration on rat retina, optic nerve and brain amino acids and monoamines.
A chronic methanol (MeOH) intoxication scheme (2 g/kg/day ip for 2 weeks) was carried out in Sprague-Dawley rats, previously depleted of folates with methotrexate (MTX). beta-Alanine (beta-Ala), 5%, was also administered to some animals in the drinking water. Amino acids were determined in plasma, retina, optic nerve, hippocampus and posterior cortex by HPLC with fluorescence detection and monoamines in retina, hippocampus and posterior cortex by electrochemical detection. Beta-Ala administration reduced taurine (Tau) levels in plasma, hippocampus and posterior cortex, but not in retina and optic nerve. Aspartate (Asp) concentration in the optic nerve was increased in MTX-MeOH treated animals, and the administration of beta-Ala did not modify this elevation. The association of beta-Ala with MTX-MeOH produced an increase of threonine, and a decrease of 5-hydroxytryptamine (5-HT) in the retina without modifying 5-hydroxyindoleacetic acid, whereas in the hippocampus an elevation of asparagine was observed. We conclude that, in the retina, beta-Ala in combination with MTX-MeOH increased serotonin and decreased dopamine (DA) turnover rate, and resulted in changes in the amino acid balance, that could affect glycinergic activity. On the other hand, in the hippocampus, Asp metabolism could be affected by Tau depletion with beta-Ala.
González-Quevedo
A
A
Instituto de Neurología y Neurocirugia, Ciudad de la Habana, Cuba.
Obregón
F
F
Urbina
M
M
Roussó
T
T
Lima
L
L
D000596:Amino Acids / Q000032:analysis* / Q000097:blood; D000818:Animals; D001216:Asparagine / Q000032:analysis; D015306:Biogenic Monoamines / Q000032:analysis*; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry; D002540:Cerebral Cortex / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D004298:Dopamine / Q000032:analysis; D004326:Drinking; D005494:Folic Acid Deficiency / Q000139:chemically induced; D006624:Hippocampus / Q000737:chemistry; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D008297:Male; D000432:Methanol / Q000008:administration & dosage / Q000633:toxicity*; D008727:Methotrexate / Q000008:administration & dosage; D009900:Optic Nerve / Q000737:chemistry / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000737:chemistry / Q000187:drug effects*; D012701:Serotonin / Q000032:analysis; D013654:Taurine / Q000032:analysis / Q000172:deficiency* / Q000502:physiology; D013912:Threonine / Q000032:analysis; D015091:beta-Alanine / Q000008:administration & dosage
D000596:Amino Acids; D015306:Biogenic Monoamines; D015091:beta-Alanine; D013654:Taurine; D013912:Threonine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D001216:Asparagine; D004298:Dopamine; D000432:Methanol; D008727:Methotrexate